{ "story_id": "8cf2378c41a64e96ce6dbcc5c2f1baab", "desk": "drm3", "revision": 1, "published_at": "2026-09-01T14:07:40.000Z", "content_hash": "ce7752b49fe821a7369fff7f7b4c12ad29690452386274c35d4812df7dd6dbab", "hash_basis": "sha256 over `headline\\ndek\\nprose`, plus `\\n` + the canonical citations JSON when any source is placed, plus `\\n#blog` for blogs", "basis": { "headline": "Trump Announces New Drug Pricing Deals with Dozen of Drugmakers", "dek": "President Trump plans to announce voluntary drug pricing deals with nearly a dozen pharmaceutical companies.", "prose": "MS NOW reported that nearly a dozen drugmakers are slated to sign voluntary deals with President Donald Trump to sell their medications for less. [^1]\n\nU.S. President Donald Trump announced drug-pricing deals with more than 20 pharmaceutical companies to reduce prescription costs, which are often nearly three times higher than those paid by patients in other developed countries. [^2]\n\nBloomberg reported that the expected deals require drugmakers to provide discounts on outpatient drugs to state Medicaid programs so prices align with foreign countries. [^3]\n\nPresident Trump is scheduled to make an announcement about healthcare affordability at 3:00 p.m. ET on Monday at the White House. [^4]\n\nThe Trump administration has reached drug pricing deals with 17 pharmaceutical companies, including Pfizer, Eli Lilly, and Novo Nordisk, as part of its 'most favored nation' policy. [^5]\n\nA second wave announced in late August added agreements with nine companies, including smaller biotechs, offering drugs to state Medicaid programs at most-favoured-nation prices. [^6]\n\nEli Lilly agreed in November to offer Medicare beneficiaries its obesity medicines Zepbound and orforglipron, branded as Foundayo, at no more than $50 per month, with additional discounts for self-pay patients through LillyDirect. [^7]\n\nThe first wave of deals included 17 major drugmakers starting last year, featuring commitments to most-favoured-nation pricing, sales through the TrumpRx.gov platform, and U.S. investment pledges in exchange for tariff relief. [^8]", "cited": "[{\"statement\":\"MS NOW reported that nearly a dozen drugmakers are slated to sign voluntary deals with President Donald Trump to sell their medications for less.\",\"source\":\"CNBC\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-08-31T17:20:45.000Z\",\"publisher_count\":1,\"sources\":[\"CNBC\"]},{\"statement\":\"U.S. President Donald Trump announced drug-pricing deals with more than 20 pharmaceutical companies to reduce prescription costs, which are often nearly three times higher than those paid by patients in other developed countries.\",\"source\":\"Investing.com\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T14:07:40.000Z\",\"publisher_count\":1,\"sources\":[\"Investing.com\"]},{\"statement\":\"Bloomberg reported that the expected deals require drugmakers to provide discounts on outpatient drugs to state Medicaid programs so prices align with foreign countries.\",\"source\":\"CNBC\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-08-31T17:20:45.000Z\",\"publisher_count\":1,\"sources\":[\"CNBC\"]},{\"statement\":\"President Trump is scheduled to make an announcement about healthcare affordability at 3:00 p.m. ET on Monday at the White House.\",\"source\":\"CNBC\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-08-31T17:20:45.000Z\",\"publisher_count\":1,\"sources\":[\"CNBC\"]},{\"statement\":\"The Trump administration has reached drug pricing deals with 17 pharmaceutical companies, including Pfizer, Eli Lilly, and Novo Nordisk, as part of its 'most favored nation' policy.\",\"source\":\"CNBC\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-08-31T17:20:45.000Z\",\"publisher_count\":1,\"sources\":[\"CNBC\"]},{\"statement\":\"A second wave announced in late August added agreements with nine companies, including smaller biotechs, offering drugs to state Medicaid programs at most-favoured-nation prices.\",\"source\":\"Investing.com\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T14:07:40.000Z\",\"publisher_count\":1,\"sources\":[\"Investing.com\"]},{\"statement\":\"Eli Lilly agreed in November to offer Medicare beneficiaries its obesity medicines Zepbound and orforglipron, branded as Foundayo, at no more than $50 per month, with additional discounts for self-pay patients through LillyDirect.\",\"source\":\"Investing.com\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T14:07:40.000Z\",\"publisher_count\":1,\"sources\":[\"Investing.com\"]},{\"statement\":\"The first wave of deals included 17 major drugmakers starting last year, featuring commitments to most-favoured-nation pricing, sales through the TrumpRx.gov platform, and U.S. investment pledges in exchange for tariff relief.\",\"source\":\"Investing.com\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T14:07:40.000Z\",\"publisher_count\":1,\"sources\":[\"Investing.com\"]}]", "kind": "news" }, "receipt_verify": "Ed25519 over the dot-joined string `slice_hash.cursor_from.cursor_to.view.view_version.row_count`; public_key and sig are base64url of the raw 32-byte key / 64-byte signature", "receipt": null, "receipt_note": "this revision predates receipt-keeping (before v0.37.0); the filed row lives in the record", "generation_chain": { "wire": { "stream": "fountain_news", "story_id": "14918d19e9dadd53df47f14685ed7e49", "thread_id": "09d8bb30ae6f3af4de5e2db50785d9a0", "thread_label": "TrumpRx", "novelty": "UPDATE", "content_hash": "214ea949d324fa1504c19bf8c6528b4a643c37100c2753ec462086c7f3c17f16", "last_published_at": "2026-09-01T14:07:40.000Z", "read_receipt": { "slice_hash": "d914d27f785e9b853b03b6d1ab1cec9b5b1654aa8667d347afa723e25ad7492c", "cursor_from": "eyJ0cyI6IjIwMjYtMDktMDFUMTM6NTk6MDkuMDAwMDAwWiIsImlkIjoiZjA1MmUxZjQ1NjYwMTY4NzA3Nzg2NDYyMzA2NDIzNWEiLCJ2IjoiMSJ9", "cursor_to": "eyJ0cyI6IjIwMjYtMDktMDFUMTQ6Mzk6MTcuMDAwMDAwWiIsImlkIjoiMjI2MTVkNjE5NDkwODViYTJkNTFhYzEwOWVmODU4MTMiLCJ2IjoiMSJ9", "view": "v_fountain_news", "view_version": "1", "row_count": 100, "window_days": 3, "bytes_scanned": 12017721, "credits": 8, "price_per_100_rows": 8, "sig": "H0e4Qo9rz4M82yXZ0wyDdl35VsMwSW5Mw2y3Y_f3rfMgREpnv54ln96KqWLU9cv127jkCWTieP34bYI6vjlCDQ", "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE", "signer_path": "lakehouse/data-extract/v1", "alg": "Ed25519", "signed": true } }, "written_at": "2026-09-02T21:39:08.076Z" }, "cited_facts": [ { "statement": "MS NOW reported that nearly a dozen drugmakers are slated to sign voluntary deals with President Donald Trump to sell their medications for less.", "source": "CNBC", "instrument": "News", "claim_key": null, "published_at": "2026-08-31T17:20:45.000Z", "publisher_count": 1, "sources": [ "CNBC" ] }, { "statement": "U.S. President Donald Trump announced drug-pricing deals with more than 20 pharmaceutical companies to reduce prescription costs, which are often nearly three times higher than those paid by patients in other developed countries.", "source": "Investing.com", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T14:07:40.000Z", "publisher_count": 1, "sources": [ "Investing.com" ] }, { "statement": "Bloomberg reported that the expected deals require drugmakers to provide discounts on outpatient drugs to state Medicaid programs so prices align with foreign countries.", "source": "CNBC", "instrument": "News", "claim_key": null, "published_at": "2026-08-31T17:20:45.000Z", "publisher_count": 1, "sources": [ "CNBC" ] }, { "statement": "President Trump is scheduled to make an announcement about healthcare affordability at 3:00 p.m. ET on Monday at the White House.", "source": "CNBC", "instrument": "News", "claim_key": null, "published_at": "2026-08-31T17:20:45.000Z", "publisher_count": 1, "sources": [ "CNBC" ] }, { "statement": "The Trump administration has reached drug pricing deals with 17 pharmaceutical companies, including Pfizer, Eli Lilly, and Novo Nordisk, as part of its 'most favored nation' policy.", "source": "CNBC", "instrument": "News", "claim_key": null, "published_at": "2026-08-31T17:20:45.000Z", "publisher_count": 1, "sources": [ "CNBC" ] }, { "statement": "A second wave announced in late August added agreements with nine companies, including smaller biotechs, offering drugs to state Medicaid programs at most-favoured-nation prices.", "source": "Investing.com", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T14:07:40.000Z", "publisher_count": 1, "sources": [ "Investing.com" ] }, { "statement": "Eli Lilly agreed in November to offer Medicare beneficiaries its obesity medicines Zepbound and orforglipron, branded as Foundayo, at no more than $50 per month, with additional discounts for self-pay patients through LillyDirect.", "source": "Investing.com", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T14:07:40.000Z", "publisher_count": 1, "sources": [ "Investing.com" ] }, { "statement": "The first wave of deals included 17 major drugmakers starting last year, featuring commitments to most-favoured-nation pricing, sales through the TrumpRx.gov platform, and U.S. investment pledges in exchange for tariff relief.", "source": "Investing.com", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T14:07:40.000Z", "publisher_count": 1, "sources": [ "Investing.com" ] } ], "note": "A signature proves who filed this and that it has not changed since. It never makes a claim true." }